Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Business (Details)

v3.24.3
Organization and Nature of Business (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 18, 2025
USD ($)
Oct. 29, 2024
$ / shares
Oct. 07, 2024
USD ($)
Nov. 02, 2023
$ / shares
Feb. 28, 2025
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
segment
$ / shares
Sep. 30, 2023
USD ($)
May 01, 2024
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Subsidiary, Sale of Stock [Line Items]                              
Number of operating segments | segment                       1      
Net loss           $ 2,280,684 $ 1,049,833 $ 1,291,335 $ 1,235,074 $ 1,440,904 $ 1,516,864 $ 4,621,852 $ 4,192,842    
Net cash used in operating activities                       2,659,297 $ 3,401,318    
Accumulated deficit           66,091,074           66,091,074     $ 61,469,222
Cash           $ 2,039,819           $ 2,039,819     $ 3,316,946
Number of days below required price per share       30 days                      
Common stock, par value | $ / shares       $ 0.0001   $ 0.0001           $ 0.0001     $ 0.0001
Minimum price per share | $ / shares       $ 1.00                   $ 1.00  
Number of days to remedy       180 days                      
Required number of days price must be over the minimum       10 days                      
Forecast                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from loan     $ 3,000,000.0   $ 3,000,000.0                    
Subsequent Events                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from loan $ 3,000,000   $ 16,500,000                        
Minimum price per share | $ / shares   $ 1.00                          
Required number of days price must be over the minimum   10 days